Statements (69)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Aurelia_Bioscience
|
| gptkbp:clinical_trial |
gptkb:m_RNA_cancer_vaccine
gptkb:drug Phase 1 Phase 2 Phase 3 COVID-19 variant vaccine m RNA flu vaccine m RNA vaccine for HPV m RNA vaccine for Zika virus m RNA vaccine for adult cancers m RNA vaccine for advanced cancers m RNA vaccine for bladder cancer m RNA vaccine for breast cancer m RNA vaccine for carcinoid tumors m RNA vaccine for colorectal cancer m RNA vaccine for esophageal cancer m RNA vaccine for glioblastoma m RNA vaccine for head and neck cancer m RNA vaccine for kidney cancer m RNA vaccine for leukemia m RNA vaccine for liver cancer m RNA vaccine for lung cancer m RNA vaccine for melanoma m RNA vaccine for metastatic cancers m RNA vaccine for multiple myeloma m RNA vaccine for neuroblastoma m RNA vaccine for non-Hodgkin lymphoma m RNA vaccine for ovarian cancer m RNA vaccine for pancreatic cancer m RNA vaccine for pediatric cancers m RNA vaccine for prostate cancer m RNA vaccine for rabies m RNA vaccine for rare cancers m RNA vaccine for retinoblastoma m RNA vaccine for sarcoma m RNA vaccine for soft tissue sarcoma m RNA vaccine for stomach cancer m RNA vaccine for testicular cancer m RNA vaccine for thyroid cancer |
| gptkbp:collaborations |
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:University_of_Pennsylvania gptkb:Coalition_for_Epidemic_Preparedness_Innovations_(CEPI) |
| gptkbp:focus |
m RNA technology
|
| gptkbp:founded |
gptkb:2000
|
| gptkbp:founder |
gptkb:Ingmar_Hoerr
|
| gptkbp:headquarters |
gptkb:Tübingen,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cure Vac Biologics
|
| gptkbp:investment |
$100 million
|
| gptkbp:ipo |
gptkb:2020
|
| gptkbp:partnership |
gptkb:GSK
gptkb:Bayer_AG |
| gptkbp:platform |
C V8102
C V7202 C V301 |
| gptkbp:products |
m RNA vaccines
|
| gptkbp:regulatory_compliance |
gptkb:FDA
gptkb:EMA |
| gptkbp:research_areas |
oncology
autoimmune diseases infectious diseases |
| gptkbp:symbol |
CVAC
|
| gptkbp:technology |
RNA-based vaccines
m RNA delivery systems m RNA therapeutics therapeutic m RNA |
| gptkbp:bfsParent |
gptkb:Cure_Vac_AG
|
| gptkbp:bfsLayer |
4
|